Document Detail

Assessment of the understanding of the risks and benefits of hormone replacement therapy (HRT) in primary care physicians.
MedLine Citation:
PMID:  16098892     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: This study was designed to assess the understanding of primary care physicians who practice in the state of Florida of the risks and benefits of hormone replacement therapy as described in the Women's Health Initiative clinical trial. STUDY DESIGN: All primary care physicians in the state of Florida, including family practice, internal medicine, and Ob/Gyn were identified and mailed an anonymous survey asking about their understanding of the risks and benefits of hormone replacement therapy (HRT), including heart disease, breast cancer, osteoporotic fractures, colon cancer, stroke, and death. Univariate statistics stratified by specialty were performed with Kruskal-Wallis one-way analysis of variance. RESULTS: Six thousand one hundred twenty-five surveys were mailed, with the return of 600 completed surveys, including 203 Ob/Gyn, 145 internal medicine, 219 family practice, and 33 other. Overall, Ob/Gyns had a more positive view of HRT, and internal medicine had a relatively negative view of HRT. In general, respondents overestimated the risk attributable to hormone replacement therapy. Ob/Gyns were significantly more likely to provide accurate assessments of these risks and benefits compared with the other specialties. Respondents correctly identified the magnitude of risks and benefits 28% of the time, 67% of the time overestimated risks and benefits, and 5% of the time misunderstood the direction of risk vs benefit of HRT. CONCLUSION: This study suggests that the findings of the Women's Health Initiative are misunderstood by the majority of primary care specialists, although Ob/Gyns have a better understanding of the risks and benefits compared to other specialties. We hypothesize that respondents that overestimate the increase or decrease in risk were making the error of confusing relative risk with absolute risk difference. There is a great need for physician education about the attributable risks and benefits of HRT.
R Stan Williams; Daniel Christie; Chris Sistrom
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  193     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-15     Completed Date:  2005-09-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  551-6; discussion 556-8     Citation Subset:  AIM; IM    
Department of Obstetrics and Gynecology, University of Florida, Gainesville, FL 32607, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Family Practice
Health Knowledge, Attitudes, Practice
Hormone Replacement Therapy* / adverse effects
Internal Medicine
Primary Health Care
Risk Assessment

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Outcomes of second-trimester pregnancy terminations with misoprostol: comparing 2 regimens.
Next Document:  The utility of HPV DNA triage in the management of cytological AGC.